Disparities in Substance Use Disorder Diagnosis and Treatment Entry Amongst LGBTQ Adults

Investigator Skills Development Unit Webinar from December 6, 2023

Learning Objectives
• Provide an overview of terminology and acronyms, including why pronouns matter
• Define minority stress theory and apply it to the development of substance use disorders (SUDs) in the LGBTQIA+ community
• Describe the disparities in the use of substances and prevalence of SUDs in analyses comparing LGBTQIA+ individuals to cisgender heterosexual peers

Dr. Andy Tompkins, preferred pronouns He/him, is currently the Director, Division of Substance Abuse and Addiction Medicine at Zuckerberg San Francisco General Hospital and a Professor of Clinical Psychiatry and Behavioral Sciences at UCSF School of Medicine. He earned his MD at New York Medical College and completed his internship and residency in psychiatry at Johns Hopkins Hospital in Baltimore, Maryland. After residency, he completed a 2-year post-doctoral fellowship in behavioral pharmacology/addictions in the Johns Hopkins Behavioral Pharmacology Research Unit and obtained a Master of Health Sciences in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Andy is the recipient of NIH, SAMHSA and industry sponsored research grants, especially in the areas of patient navigation, chronic pain and medication development for the treatment of opioid use disorder. He has authored or co-authored 47 peer-reviewed manuscripts, two book chapters, and presented at dozens of national and international scientific meetings in the areas of chronic pain, substance use disorders and the intersection of religion and queer identity. In his role at UCSF, he oversees a Division that serves 1500 patients yearly suffering with substance use disorders and maintains an active clinical practice at the OTOP/Ward 93 licensed opioid treatment program. Lastly, Dr. Tompkins has been a strong advocate for the LGBTQIA+ community, starting the first LGBT student group at his medical school, helping to bring back gender affirming surgical care at Hopkins after 40 years without it, advocating for the passage of marriage equality in Maryland, using his leadership in the American Psychiatric Association to strongly defend against anti-trans legislation, and leading the newly formed LGBTQIA+ Subcommittee in the College of Problems of Drug Dependence.

Presented by the Investigator Skills Development Unit (ISDU) of the
UCSF Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases (RCC-RD-MCD)
(MPIs: E. Charlebois, PhD, MPH; K. Rhoads, MD, MPH; S. Gansky, DrPH)
Co-Sponsored by CAPS Town Hall
ISDU Director and Session Moderator: Mandana Khalili, MD, MAS, Professor of Medicine, UCSF, Chief of Clinical Hepatology, San Francisco General Hospital

ISDU Co-Director: Edwin Charlebois, PhD, MPH Professor of Medicine, Division of Prevention Science, UCSF